These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8990427)

  • 1. Effect of intramuscular 15-methyl prostaglandin F2 alpha after second-trimester delivery.
    Carlan SJ; Gushwa JP; O'Brien WF; Vu T
    Obstet Gynecol; 1997 Jan; 89(1):5-9. PubMed ID: 8990427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study.
    Leader J; Bujnovsky M; Carlan SJ; Triana T; Richichi K
    Obstet Gynecol; 2002 Oct; 100(4):689-94. PubMed ID: 12383535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraamniotic prostaglandin F2 alpha for pregnancy termination in the second and early third trimesters of pregnancy.
    Lipitz S; Grisaru D; Libshiz A; Rotstein Z; Schiff E; Lidor A; Achiron R
    J Reprod Med; 1997 Apr; 42(4):235-8. PubMed ID: 9131497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of laminaria placement for cervical ripening in second trimester termination of pregnancy induced by intra-amniotic injection of prostaglandin F(2)alpha followed by concentrated oxytocin infusion.
    Almog B; Levin I; Winkler N; Fainaru O; Pauzner D; Lessing JB; Gamzu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):32-5. PubMed ID: 15596269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction.
    Farah LA; Sanchez-Ramos L; Rosa C; Del Valle GO; Gaudier FL; Delke I; Kaunitz AM
    Am J Obstet Gynecol; 1997 Aug; 177(2):364-9; discussion 369-71. PubMed ID: 9290452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraamniotic 15(s)-15-methyl prostaglandin F2 alpha and termination of middle and late second-trimester pregnancy for genetic indications: a contemporary approach.
    Ferguson JE; Burkett BJ; Pinkerton JV; Thiagarajah S; Flather MM; Martel MM; Hogge WA
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):332-9; discussion 339-40. PubMed ID: 8362944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of intraumbilical vein oxytocin in midtrimester pregnancy losses.
    Bivins HA; Cope DA; Newman RB; Eller DP
    Am J Obstet Gynecol; 1993 Oct; 169(4):1070-3. PubMed ID: 8238122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.
    Adnan N; Boland F; Murphy DJ
    Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2 alpha gel and prostaglandin E2 pessary.
    Majoko F; Zwizwai M; Nyström L; Lindmark G
    Cent Afr J Med; 2002; 48(11-12):123-8. PubMed ID: 14562597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraumbilical vein injection of oxytocin and the third stage of labor: randomized double-blind placebo trial.
    Ghulmiyyah LM; Wehbe SA; Saltzman SL; Ehleben C; Sibai BM
    Am J Perinatol; 2007 Jun; 24(6):347-52. PubMed ID: 17564955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbetocin versus syntometrine in the management of third stage of labor following vaginal delivery.
    Askar AA; Ismail MT; El-Ezz AA; Rabie NH
    Arch Gynecol Obstet; 2011 Dec; 284(6):1359-65. PubMed ID: 21336835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraamniotic prostaglandin F2 alpha for intrauterine death and fetal abnormality.
    Luengo J; Keirse MJ; Bennebroek Gravenhorst J
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):325-9. PubMed ID: 299460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrafetal prostaglandin F2 alpha administration for midtrimester pregnancy termination: a case report.
    Christodoulou CN; Kotoulas IG; Agapitos EB; Germanos AK
    Am J Obstet Gynecol; 1990 May; 162(5):1245-6. PubMed ID: 2187355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.